Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes
Author:
Affiliation:
1. Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama, Japan
Publisher
Japan Endocrine Society
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.jstage.jst.go.jp/article/endocrj/66/4/66_EJ18-0417/_pdf
Reference20 articles.
1. 1 Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y (2000) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 342: 301–307.
2. 2 Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, et al. (2003) Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 26: 2345–2352.
3. 3 Kawabata Y, Ikegami H, Awata T, Imagawa A, Maruyama T, et al. (2009) Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 52: 2513–2521.
4. 4 Imagawa A, Hanafusa T (2006) Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud 3: 169–177.
5. 5 Shibasaki S, Imagawa A, Tauriainen S, Iino M, Oikarinen M, et al. (2010) Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes. Endocr J 57: 211–219.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Case of Fulminant Type 1 Diabetes with Transient Production of Anti-Glutamic Acid Decarboxylase Antibody;American Journal of Case Reports;2024-03-28
2. Pediatric fulminant type 1 diabetes with glutamic acid decarboxylase antibody;Pediatrics International;2020-11-04
3. Possible involvement of autoimmunity in fulminant type 1 diabetes;Diabetology International;2020-08-27
4. Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports;BMC Endocrine Disorders;2019-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3